Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03564340 |
|---|---|
| Brief Title: | Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
| First Submitted : | May 17, 2018 |
| First Submitted that Met QC Criteria : | June 8, 2018 |
| First Posted : | June 20, 2018 |
| Last Update Submitted that Met QC Criteria : | April 12, 2024 |
| Last Update Posted : | April 15, 2024 |